当前位置:首页 - 行情中心 - 科伦药业(002422) - 财务分析

科伦药业

(002422)

  

流通市值:468.68亿  总市值:573.54亿
流通股本:13.06亿   总股本:15.98亿

科伦药业(002422)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润11.14亿元,每股收益0.63元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益2866500.60万元,未分配利润1180275.41万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产3905050.24万元,负债1038549.64万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入9,083,327,6204,389,897,04521,812,414,48916,788,775,173
营业总成本7,818,465,9813,728,008,89217,850,873,64613,414,966,751
其他经营收益
营业利润1,513,437,194793,737,6894,426,321,4613,809,979,491
利润总额1,417,649,449773,184,7024,285,358,8243,705,661,963
净利润1,113,856,403659,587,4763,361,954,3932,921,005,577
每股收益
其他综合收益-39,588,443-6,264,06611,139,131-17,620,214
综合收益总额1,074,267,960653,323,4103,373,093,5242,903,385,363
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计19,583,664,73718,489,123,74217,935,981,25019,065,882,897
非流动资产:
非流动资产合计19,466,837,70019,337,105,13919,380,278,23219,326,481,078
资产总计39,050,502,43737,826,228,88137,316,259,48238,392,363,975
流动负债:
流动负债合计9,075,838,5909,092,533,2329,137,877,76810,142,720,730
非流动负债:
非流动负债合计1,309,657,8311,302,768,9461,440,199,6412,018,200,473
负债合计10,385,496,42110,395,302,17810,578,077,40912,160,921,203
所有者权益(或股东权益):
归属于母公司股东权益合计23,679,226,04123,094,459,07822,479,520,44622,555,029,731
股东权益合计28,665,006,01627,430,926,70326,738,182,07326,231,442,772
负债和股东权益合计39,050,502,43737,826,228,88137,316,259,48238,392,363,975
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计10,728,655,7825,184,117,25325,767,456,08219,166,712,485
经营活动现金流出小计9,539,120,9054,734,733,00921,274,594,23815,891,287,905
经营活动产生的现金流量净额1,189,534,877449,384,2444,492,861,8443,275,424,580
投资活动产生的现金流量:
投资活动现金流入小计12,803,165,5084,018,350,90811,317,443,4649,555,768,110
投资活动现金流出小计13,331,669,6274,708,422,26813,136,811,45510,945,429,500
投资活动产生的现金流量净额-528,504,119-690,071,360-1,819,367,991-1,389,661,390
筹资活动产生的现金流量:
筹资活动现金流入小计3,819,952,5411,430,590,9955,621,292,5454,860,746,513
筹资活动现金流出小计2,651,968,4291,063,394,1728,925,568,6516,229,432,608
筹资活动产生的现金流量净额1,167,984,112367,196,823-3,304,276,106-1,368,686,095
汇率变动对现金及现金等价物的影响-2,186,9653,846,622-12,779,820-10,344,335
现金及现金等价物净增加额1,826,827,905130,356,329-643,562,073506,732,760
期末现金及现金等价物余额5,771,589,9794,075,118,4033,944,762,0745,095,056,907
补充资料:
现金及现金等价物的净增加额1,826,827,905--643,562,073-
最新报告期:2025-09-04
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
东海证券杜永宏1.421.802.142025-09-04
华源证券刘闯,李强1.511.842.172025-09-03
太平洋周豫1.781.892.002025-09-01
野村东方国际证券孔令岩1.521.711.942025-09-01
中国银河孙怡,程培1.051.411.702025-08-29
TOP↑